COMMUNIQUÉS West-GlobeNewswire

Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
14/10/2026
First clinical data for leniolisib in a larger group of PID participants beyond APDS, supporting the potential of targeted PI3Kδ inhibition to address immune dysregulation Leniolisib was well-tolerated, with benefits [...]
Orion publishes Interim Report for January–September 2026 and holds a webcast on 28 October 2026
14/10/2026
ORION CORPORATION PRESS RELEASE 14 OCTOBER 2026 at 9.00 EEST Orion publishes Interim Report for January–September 2026 and holds a webcast on 28 October 2026 Orion will publish Interim Report for January–September 2026 [...]
Orum Therapeutics Doses First Patient in Phase 1 Trial of ORM-1153, a CD123-GSPT1 Degrader-Antibody Conjugate
14/10/2026
BOSTON and DAEJEON, South Korea, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today [...]
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
14/10/2026
-- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price list -- -- IMCIVREE is the first approved therapy in Japan for patients living [...]
Shoreline Medical Administration, CHUM Health and Cellution Biologics Launch Elite Graft Program for Advanced Wound Care
13/10/2026
New collaborative program brings together an industry leading biologic graft, wound care specific revenue cycle management and the only clawback protection program in one coordinated solution ROSWELL, Ga., Oct. 13, 2026 [...]
Eye2Eye Foundation Announces Free Thyroid Eye Disease Patient Seminars in Houston and Woodland Hills Featuring Dr. Raymond Douglas
13/10/2026
Complimentary gatherings in Houston and Woodland Hills will connect people affected by thyroid eye disease with clinical experts, patient-focused education and practical financial-navigation guidance. Beverly Hills, CA [...]
Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program
13/10/2026
Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026 Previously announced asset sale transactions with PTC and Lilly have closed, generating $163. [...]
Acquisition of Own Shares
13/10/2026
Mechelen, Belgium; October 13, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
13/10/2026
-- NOV-ERA is designed to assess the efficacy and safety of ontunisertib in approximately 320 patients with symptomatic Fibrostenosing Crohn's disease (FSCD) -- -- Global, randomized, placebo-controlled, dose-ranging [...]
OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026
13/10/2026
WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Rani Therapeutics to Participate in the Chardan Healthcare Conference
13/10/2026
SAN JOSE, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s [...]
CapsoVision to Present at the 20th Annual LD Micro Main Event
13/10/2026
SARATOGA, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced [...]
Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist
13/10/2026
Mean weight reduction ranged from 1.5% to 3.2% at Day 29 across Cohorts 1-4, compared with 0.1% for pooled placebo. No severe or serious TEAEs, no TEAE-related dose modifications, and no TEAE-related discontinuations [...]
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
13/10/2026
Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions Generate will [...]
Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
13/10/2026
Press release – No. 20 / 2026 Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases Collaboration will combine [...]
TRexBio Announces Closing of Initial Public Offering
13/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. (“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of [...]
Texas Legends, Block Party Energy, and One Big Ribbon: Ally Medical ER Frisco Makes It Official
13/10/2026
Neighbors, families, and community leaders joined Ally Medical ER for an evening of food, fun, and celebration at the city’s newest emergency room FRISCO, Texas, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency [...]
BayCare Celebrates a Decade as a Fortune Best Workplace in Health Care™
13/10/2026
CLEARWATER, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Great Place To Work® and Fortune magazine have named BayCare Health System to the national list of 2026 Fortune Best Workplaces in Health Care. This marks the 10th [...]
Standard Process® Announces Launch of MediHerb® GLP-1 Bitter Complex
13/10/2026
New herbal formula combines Hops and Feverfew extracts to support satiety, healthy digestion, and metabolism through the body’s natural response to bitter ingredients.* A Media Snippet accompanying this announcement is [...]

Pages